Description
NandroRapid
Specification
| Common | |
| Active substance | Nandrolone Phenyl-prop |
| Indications | NandroRapid is indicated for treatment of anemia’s, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner’s syndrome and prophylaxis of hereditary angioedema. |
| Dosage | |
| Quantity | |
| Unit | |
| Time | |
| Potency | |
| Quantity | 100 |
| Unit | Milligram/Milliliter |
| Packaging | |
| Quantity | 10 |
| Unit | Ampul |
| Type | Carton |
| Presentation | Each carton contains 10 ampoules of 1ml (100mg/ml) |
